Cargando…
Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics
Gram-negative resistance remains a major challenge. Rates of in vitro resistance to commonly utilized antibiotics have skyrocketed over the last decade. Clinicians now encounter multidrug-resistant organisms routinely. Fortunately, newer agents, such as ceftazidime–avibactam, ceftolozone–tazobactam,...
Autores principales: | Waters, Jessica, Shorr, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294883/ https://www.ncbi.nlm.nih.gov/pubmed/37370296 http://dx.doi.org/10.3390/antibiotics12060977 |
Ejemplares similares
-
Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
por: Kontou, Angeliki, et al.
Publicado: (2023) -
Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria
por: Taneja, Neelam, et al.
Publicado: (2016) -
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020) -
224. Clinical Relevance of Antibiotic Tolerance in Recurrent Gram-negative Bloodstream Infections
por: Parsons, Joshua B, et al.
Publicado: (2023) -
Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)